STAAR Surgical Files 8-K on Financial Condition

TL;DR

**STAAR Surgical just dropped an 8-K on its financials, giving us a peek at their latest numbers.**

AI Summary

STAAR Surgical Company filed an 8-K on February 26, 2024, reporting on its results of operations and financial condition. The filing indicates that the company, incorporated in Delaware with IRS Employer Identification No. 95-3797439, is located at 25651 Atlantic Ocean Drive, Lake Forest, California 92630. This report was filed under the Securities Exchange Act of 1934, with a Commission File Number of 0-11634.

Why It Matters

This filing provides an update on STAAR Surgical's financial health, which is crucial for investors to assess the company's performance and future prospects.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure of financial condition and does not indicate any immediate new risks or significant changes.

Key Numbers

• 0-11634 — Commission File Number (SEC identification for STAAR Surgical Company)
• 95-3797439 — IRS Employer Identification No. (Tax identification for STAAR Surgical Company)

Key Players & Entities

• STAAR Surgical Company (company) — Registrant
• Delaware (company) — State of Incorporation
• 95-3797439 (dollar_amount) — IRS Employer Identification No.
• 0-11634 (dollar_amount) — Commission File Number
• February 26, 2024 (date) — Date of earliest event reported

FAQ

Filing Documents

• staa-20240226.htm (8-K) — 39KB
• staa-ex99_1.htm (EX-99.1) — 1221KB
• img177331332_0.jpg (GRAPHIC) — 11KB
• 0000950170-24-020126.txt ( ) — 1428KB
• staa-20240226.xsd (EX-101.SCH) — 29KB
• staa-20240226_htm.xml (XML) — 4KB

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On February 26, 2024, STAAR Surgical Company (the "Company") published a press release reporting its financial results for the quarter and year ended December 29, 2023, a copy of which is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference. This information and the information contained in the press release shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in Item 2.02 of this Current Report and Exhibit 99.1 shall not be incorporated by reference into any filings of the Company made under the Securities Act of 1933, as amended, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing unless specifically stated so therein .

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits Exhibit No. Description 99.1 Press release of the Company dated February 26, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STAAR Surgical Company February 26, 2024 By: /s/ Tom Frinzi Thomas G. Frinzi President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR